Introduction {#s001}
============

G[ram-negative bacteria]{.smallcaps} are among the most troublesome microorganisms, as they are becoming increasingly intransigent to antibiotic treatment. These include a multitude of organisms, some of which cause respiratory problems such as *Haemophilus influenzae*, *Klebsiella pneumoniae*, *Legionella pneumophila*, *Pseudomonas aeruginosa*; urinary tract infections as with *Escherichia coli*, *Proteus mirabilis*, *Enterobacter cloacae*, *Serratia marcescens*; or gastrointestinal problems as in the cases of *Helicobacter pylori*, *Salmonella enteritidis* and *Salmonella typhi*. In addition, other bacteria such as *P. aeruginosa* are associated with hospital-acquired infections, such as meningitis and pneumonia in hospital intensive care units.

The bacterial cell wall is comprised of crosslinked strands of peptidoglycan (PG), which encase the entire cytoplasmatic membrane. A healthy cell wall is critical for survival of bacteria and homeostasis requires simultaneous biosynthetic and degradative processes. Gram-negative bacteria have evolved to recycle the cell wall that is degraded, as a means of existence. During a single doubling process, up to 60% of the PG is turned over in Gram-negative bacteria. Cell wall-active antibiotics such as β-lactams cause defect in the cell wall,^[@B1]^ which leads to the degradative events to generate some of the same recycling intermediates. This is the common link between the two events. A large number of enzymes are involved in these processes.

AmpD peptidoglycan amidases in cell wall recycling {#s002}
--------------------------------------------------

Bacterial cell wall recycling is set in motion by degradation of PG, the major constituent of the cell wall, by the action of lytic transglycosylases^[@B4]^ ([Fig. 1](#f1){ref-type="fig"}). These enzymes digest the peptidoglycan saccharide backbone to generate various fragmentation products, referred to as muropeptides.^[@B7]^ The major end product is *N*-acetyl-β-[d]{.smallcaps}-glucosamine-(1--4)-1,6-anhydro-*N*-acetyl-β-[d]{.smallcaps}-muramyl-peptide (NAG-anhNAM-peptide, **1** in [Fig. 2](#f2){ref-type="fig"}), which is internalized to the cytoplasm by the permease AmpG. As studied in the system in *Citrobacter freundii*, once in the cytoplasm, the disaccharide is hydrolyzed by glucosaminidase NagZ to result in 1,6-anhydro-*N*-acetyl-β-[d]{.smallcaps}-muramyl-peptide (anhNAM-peptide, **2** in [Fig. 2](#f2){ref-type="fig"}) and *N*-acetylglucosamine, which then serves as the substrate for the protease AmpD. Thus, AmpD peptidoglycan amidase removes the peptide stem from anhydro-*N*-acetyl-β-[d-]{.smallcaps}muramyl-peptide (**2**) at the amide bond of the lactyl moiety^[@B8]^ ([Fig. 1](#f1){ref-type="fig"}). AmpD exhibits high selectivity for anhydromuramyl peptides and this selectivity ensures that AmpD participates in muropeptide recycling without degrading other potential peptide substrates. This reaction takes place in the bacterial cytoplasm and its substrate is believed to be an important player both in the peptidoglycan recycling events and in an induction process that leads to the expression of β-lactamase, a key β-lactam antibiotic resistance enzyme ([Fig. 1](#f1){ref-type="fig"}). Removal of the peptide from the substrate for AmpD ([Fig. 1](#f1){ref-type="fig"}) is at the crossroads of the induction of the AmpC β-lactamase and commitment to recycling of the cell wall.^[@B2],[@B5],[@B9]^ That is to say that the AmpD reaction shuts down the mechanism for the induction of β-lactamase production and directs the process to recycling.

![General cell wall recycling mechanism in Gram-negative bacteria. Figure adapted from Ref.^[@B14]^ *Yellow* bond indicates where AmpD, AmpDh2, and AmpDh3 cleave. *Red* and *blue lines* indicate bonds cleaved by LTs and NagZ, respectively.](fig-1){#f1}

![Chemical structures of synthetic substrates and product analog used for this study.](fig-2){#f2}

*P. aeruginosa*, in contrast to other organisms, has three closely related AmpD enzymes. Their roles in the link between the biochemical steps of recycling and inducible antibiotic resistance mechanism involving the AmpC β-lactamase have only been elucidated recently^[@B8],[@B10]^ ([Fig. 1](#f1){ref-type="fig"}). In contrast to other Gram-negative bacteria, peptidoglycan recycling in *P. aeruginosa* shows certain particularities inclusive of the PG amidases designated AmpD, AmpDh2, and AmpDh3.^[@B11]^ The localization of these enzymes is critical for their functions. AmpD is clearly cytoplasmic, consistent with the observed localization of AmpD homologs in other species, as it turns over only the muropeptide substrate that is transported to the cytoplasm (such as compounds **1** or **2** in [Fig. 2](#f2){ref-type="fig"}).^[@B8]^ AmpDh2 and AmpDh3, in contrast, are periplasmic, with AmpDh2 anchored to the inner leaflet of the outer membrane,^[@B10]^ whereas AmpDh3 is soluble in the periplasm.^[@B8]^ These enzymes act on the peptidoglycan as well as muropeptides of various lengths, which they would encounter only in the periplasmic space (such as compound **3** in [Fig. 2](#f2){ref-type="fig"}). The presence of these amidases in *P. aeruginosa* would appear to confer fitness associated with virulence.^[@B10]^

AmpDh2 and AmpDh3 show 42% and 46% amino acid sequence identity (57% amino acid sequence similarity in both cases) to *E. coli* AmiD, respectively. The fact that both the *P. aeruginosa* AmpDh2 and the *E. coli* AmiD^[@B10]^ are anchored to the inner leaflet of the outer membrane would suggest that AmpDh3 is an extra amidase in *P. aeruginosa*. Indeed, by infecting mice with the knockout strains of AmpD, AmpDh2, and AmpDh3, AmpDh3 would appear to be a bigger contributor than AmpDh2 to repression of *ampC* in an *ampD* mutant. Nonetheless, AmpDh2 and AmpDh3 also play a role in virulence, which is much less understood.^[@B11]^

Catalytic mechanism(s) of AmpD, AmpDh2, and AmpDh3 {#s003}
--------------------------------------------------

Notwithstanding that both AmpDh2 and AmpDh3 turnover the peptidoglycan, they exhibit differences in their activities in that variations exist as in the degradation pattern of the peptidoglycan. For example, their specific activities are different, they exhibit differences in their choice of saccharides for substrates (compound **2** vs. **3** in [Fig. 2](#f2){ref-type="fig"}), their abilities to turn over the PG at sites of crosslinking or elsewhere, and in their release of muropeptides or alterations of the polymeric segments (which are not released).^[@B8],[@B12],[@B13]^ Overall, the activities of the two enzymes complement each other. Intriguingly, the cytoplasmic AmpD requires an activation mechanism,^[@B14]^ which is not seen in AmpDh2 and AmpDh3. The belief is that if AmpD were to be unregulated for its hydrolytic activity, it might show promiscuity in substrate turnover, which might be detrimental for a cytoplasmic enzyme.^[@B14]^

As indicated earlier, the kinetic parameters for turnover of synthetic substrates (compounds 1--3) of different AmpD enzymes from *P. aeruginosa* have been evaluated^[@B8]^ using diverse muropeptides and peptidoglycan-based surrogates for the cell wall. As expected, the catalytic machineries of these proteins resemble those of typical zinc ion-dependent proteases. The X-ray structures show the typical active site ensconcing the zinc ion, which on incubation with the metal chelator EDTA leads to enzyme inactivation. Yet, the substrates that they turn over are distinct. The reactions with synthetic substrates reveal that AmpD shows activity with 1,6-anhydromuramyl derivatives (compounds **2**), whereas AmpDh2 and AmpDh3 present activity with two different types of substrates (1,6-anhydromuramyl derivatives, **2** and muramyl analogs, **3**).^[@B8]^ The separate analyses of turnover of the polymeric sacculus for both the soluble and insoluble fractions revealed that the AmpDh2 reaction products are seen more prominently in the soluble fraction, whereas that of AmpDh3 is seen more in the insoluble polymeric portion. In addition, the existence of partial hydrolysis reaction (less exhaustive turn over) is more significant in the case of AmpDh2 compared with AmpDh3.^[@B12]^ In essence, it would appear that AmpDh2 hydrolyzes at the peripheries of the sacculus, which become soluble fractions, and AmpDh3 hydrolyzes the stem peptides on the core of the sacculus, where the change remains associated with the polymeric fraction.

Three-dimensional structures of AmpD enzymes {#s004}
--------------------------------------------

AmpD peptidoglycan amidases are T7 lysozyme-type metallopeptidases and belong to the amidase 2 family (PF01510), according to the Pfam classification.^[@B15]^ All members are zinc ion-dependent amidases with a single Zn^+2^ in the active site,^[@B15]^ with a canonical folding constituted by a five-stranded parallel β-sheet surrounded by β-helices. The zinc ion at the active site is positioned on one side of the β-sheet and is tetrahedrally coordinated by a water molecule.^[@B16]^ The amidase 2 family includes enzymes from different pathogenic species (*e.g.*, *Mycobacterium tuberculosis*, *Streptococcus pneumoniae*, *Staphylococcus aureus*, *Clostridium botulinum* among others) and the peptidoglycan-recognition proteins (PGRPs) that are pattern-recognition proteins that bind and/or hydrolyze PG of the bacterial cell walls.^[@B17]^ PGRPs are found in both invertebrates and vertebrates, but have developed different functions from host signaling pathways^[@B20]^ to bactericidal functions.^[@B22]^ In general, peptidoglycan amidase genes code for proteins of 20--30 kDa and exhibit a minimum of 54% amino acid sequence similarity.

AmpD {#s005}
----

The reported NMR structure of AmpD from *C. freundii* (no structural information has been reported for the *P. aeruginosa* ortholog) revealed, for the first time, similarities with bacteriophage T7 lysozyme and with eukaryotic PGRPs.^[@B25]^ This structure presented a small active site incapable of accommodating its substrate. The crystal structures of AmpD in its apo- and holoenzyme forms at two different pH values, as well as in complex with the reaction products revealed a structure that, while preserving the general fold observed in the NMR structure, exhibited a larger active site around the catalytic zinc ion^[@B14]^ ([Fig. 3a](#f3){ref-type="fig"}). A large rmsd value of 3.9 Å (for all Cα atoms) was calculated from superimposing NMR and crystal structures, indicating that the highest changes were concentrated in four specific regions of the protein (r1--r4) surrounding the catalytic zinc ion ([Fig. 3a](#f3){ref-type="fig"}). Since AmpD crystals in the presence of the substrate showed catalytic activity, the crystal structure conformation was proposed to be the enzyme active form, while the NMR structure was considered to be that of the inactive form by exhibiting a "closed" conformation.^[@B14]^ The reason why this PG amidase would present such activation mechanism is still unknown; however it is likely that in the cytoplasm this enzyme would have fortuitous proteolytic activities that an activation mechanism would moderate.^[@B14]^ In addition, sequence conservation of the regions involved in activation of all bacterial cytosolic AmpD enzymes and in some intracellular PGRP with peptidase activity (but not in periplasmic or extracellular enzymes) further supports this hypothesis.

![Three-dimensional structures of the different AmpDs in their monomeric forms. **(a)** Structural superimposition of AmpD on its inactive (NMR, colored in *orange*) versus its active state (X-ray, colored in *green*). **(b)** Structural superimposition of the active form of cytosolic AmpD (*green* cartoon), the catalytic domain of periplasmic AmpDh2 (*blue* cartoon) and the catalytic domain of periplasmic AmpDh3 (*pink* cartoon). **(c)** Crystal structure of the monomer of AmpDh2 showing the multidomain arrangement. The N-terminal coiled-coil/loop colored in *gray*, the catalytic domain colored in *blue* and the PG-binding domain colored in *yellow*. **(d)** Crystal structure of the monomer of AmpDh2 showing the multidomain arrangement. The N-terminal coiled-coil/loop colored in *gray*, the catalytic domain colored in *blue* and the PG-binding domain colored in *yellow*.](fig-3){#f3}

AmpDh2 and AmpDh3 {#s006}
-----------------

The crystal structures of AmpDh2 and AmpDh3 have been reported for the apo forms and in complexes with different substrate/product analogues.^[@B12],[@B13]^ Both enzymes present similar multidomain structures ([Fig. 3c, d](#f3){ref-type="fig"}) with an N-terminal coiled-coil/loop, a catalytic domain similar to that found in the cytoplasmic AmpD ([Fig. 3b](#f3){ref-type="fig"}) and, finally, a globular C-terminal domain assigned as the peptidoglycan-binding domain based on Pfam annotation for this domain (PF01471). Both the peptidoglycan-binding domain and the N-terminal coiled-coil/loop, critical in the oligomeric state of AmpDh2 and AmpDh3 (see below), are not present in the cytoplasmic AmpD. Detailed structural comparison of the catalytic domains of the cytoplasmic and periplasmic paralogues reveals that while the r4 region, which is critical in substrate recognition of the cytosolic AmpD, is conserved in both AmpDh2 and AmpDh3 ([Fig. 3b](#f3){ref-type="fig"}), regions r1, r2, and r3, key in the activation process of AmpD, are absent in the periplasmic enzymes. Sequence analysis reveals that the multidomain arrangement (Amidase 2 domain, followed by the PG-binding domain) observed in AmpDh2 and AmpDh3 is less common than the single-domain disposition of its cytoplasmic paralogue (177 sequences vs. 1728 sequences, as determined by Pfam). This modular architecture is found primarily (82%) in Gram-negative bacteria (*Pseudomonas* sp., *Rhodopseudomonas* sp., *Rhizobium* sp., *Burkholderia* sp., and *Yersinia*, among others) and in few Gram-positives (*Clostridium* sp., *Mycobacterium* sp., *Streptomyces* sp., among others). In contrast, the single-domain architecture having the Amidase_2 domain is largely distributed among various bacteria (as a part of the cell wall remodeling machinery), but also in insect and mammals (as a consequence of the incorporation of Amidase_2 domain in their immune system as pattern-recognition proteins), as assessed by the program Pfam.

Importantly, the oligomeric state is different for each AmpD paralogue, something that seems to be related to both their specificity for substrates and regulation. Cytoplasmic AmpD presents a globular monomer of around 40 × 49 Å dimensions for the active-site face ([Fig. 4a](#f4){ref-type="fig"}). AmpDh2 is a large homodimer (60 × 69 Å) ([Fig. 4b](#f4){ref-type="fig"}), both in the crystal and in solution.^[@B13]^ The long N-terminal loop allows both the formation of the dimer and the anchoring of the oligomer to the inner leaflet of the bacterial outer membrane. Interestingly (as detailed below) the dimer also provides a more extensive surface for recognition of the cell wall.^[@B13]^ On the other hand, the periplasmic AmpDh3 is soluble and is folded in a very large tetrameric arrangement of around 74 × 87 Å ([Fig. 4c](#f4){ref-type="fig"}). The N-terminal coiled-coil/loop and an extra α helix (α2 in [Fig. 3d](#f3){ref-type="fig"}), not present in homologous AmpDh2, provide a strong network of interactions that allow the formation of the tetramer in AmpDh3. This tetramer displays two active sites in one side of the oligomer and the other two in the back, allowing a multivalent binding of AmpDh3 onto the cell wall, which lends itself to its processive remodeling.^[@B12]^

![Oligomeric state and cell wall binding in AmpD enzymes. The enzyme structures are given as ribbon representation **(a--c)** and Connolley surface **(d--g)**. The ligands are depicted as capped sticks. **(a)** Crystal structure of AmpD from *Citrobacter freundii* (*green* cartoon) in complex with anhNAM(pentapetide), **2c** (PDB code 2Y2B). **(b)** Combined structures of AmpDh2 from *Pseudomonas aeruginosa* in complex with **2c** and complex with **4** (PDB codes 4BOL and 4BPA, respectively). **(c)** Crystal structure of the tetramer of AmpDh3 from *P. aeruginosa* in complex with (NAG-NAM(pentapeptide))~2~, **5** (PDB code 4BXD). **(d)** Detail of the active site of AmpD from *C. freundii* in complex with anhNAM(pentapetide), **2c** (depicted as capped sticks). **(e)** Detail of the active site of AmpDh3 from *P. aeruginosa* in complex with anhNAM(pentapetide), **2c** (PDB code 4BXE). **(f)** Detail of the active site of AmpDh2 from *P. aeruginosa* in complex with **2c** and with **4** (PDB codes 4BOL and 4BPA, respectively). Surface of monomers colored as in **(b)**. **(g)** Detail of the active site of AmpDh3 from *P. aeruginosa* in complex with (NAG-NAM(pentapetide))~2~, **5**. Surface of monomers colored as in **(c)**.](fig-4){#f4}

PG recognition by AmpD enzymes {#s007}
------------------------------

Each of the AmpD paralogues presents different substrate specificity. While cytoplasmic AmpD can recognize NAG-anhNAM(pentapeptide) (**1**) or just anhNAM(pentapeptide) (**2**), the periplasmic paralogues AmpDh2 and AmpDh3 can recognize noncrosslinked and even crosslinked cell wall. The study of the reaction of ApmDh2 and AmpDh3 with the pseudomonal sacculus by LC/MS and LC/MS/MS revealed that both enzymes turn over the sacculus.^[@B8],[@B12],[@B13]^ However, there are relevant differences between cell wall degradation by AmpDh3 and AmpDh2. While AmpDh3 exhibits most of its reactions with the polymeric insoluble sacculus fraction, those of AmpDh2 are mostly found in the soluble fractions,^[@B12]^ as mentioned earlier. Furthermore, AmpDh3 produces more products for complete hydrolysis (higher specific activity), whereas AmpDh2 produced significantly more partial-reaction products.^[@B12]^ The three-dimensional structures of the different paralogues have revealed an exquisite adaptation of the common structural fold to fine tune recognition of each substrate.

The active site of AmpD presents both a glycan-binding site in which the 1,6-anhydro-*N*-acetylmuramyl moiety is accommodated and a peptide-binding site in which the peptide stem is bound ([Fig. 4d](#f4){ref-type="fig"}). The PG-binding site of AmpD presents a similar topography to that of PGRPs.^[@B20],[@B26]^ The groove is ∼26 Å long, with a narrow region near the active site and broader segments at the ends. The main differences between PG-binding cleft in AmpD and PGRPs are the entire r2 region and, to a less extent, the r1 region.^[@B14]^ Different residues stabilize the ligand (**2c**) inside the binding site, among them three residues (Asn35, Lys162, and Tyr63) are critical in orientation of the 1,6-anhydro-*N*-acetylmuramyl moiety through hydrogen bonds. In agreement with this result, reported mutagenesis studies revealed that modification of Tyr63 or Lys162 resulted in strong attenuation of the AmpD activity.^[@B29]^ Specificity of AmpD for the diaminopimelate (DAP) moiety of the peptide stem is provided by Arg71 in accordance with previously reported relevance of Arg or Asp residues at this position in PGRPs, depending on DAP or Lys specificity,^[@B30],[@B31]^ respectively. Interestingly, crystal structure of AmpDh3 in complex with 1,6-anhydro-NAM(pentapeptide), **2c**^[@B12]^ ([Fig. 4e](#f4){ref-type="fig"}) reveals that recognition of this ligand is also performed by the periplasmic enzyme, but presenting a much larger cavity and without specificity for the 1,6-anhydro-*N*-acetylmuramyl moiety.

Crystal structures of AmpDh2 and AmpDh3 in complex with different ligands (compounds **2c**, **4**, and **5**)^[@B12],[@B13]^ ([Fig. 4f, g](#f4){ref-type="fig"}) provided explanation for the differential specificities found in both periplasmic paralogues. The AmpDh2 active site is an L-shaped cavity with a 24 Å-long segment for the peptide stem binding and a 30 Å-long segment for glycan binding, with the catalytic zinc ion located at the junction of the two binding sites. The active site can accommodate nicely chains of the NAG-NAM backbone ([Fig. 4f](#f4){ref-type="fig"}), thanks to both the long groove starting at the catalytic domain and extending to the peptidoglycan-binding domain and the β5--β6 motif that clamps down on the substrate. Interestingly, the peptide-binding site is lengthened to ∼49 Å by the surface groove of the other monomer in the oligomer ([Fig. 4f](#f4){ref-type="fig"}), explaining the binding and degradation of the crosslinked portions of the cell wall by AmpDh2.^[@B13]^ In AmpDh3 an L-shaped active site defines a 22 Å-long peptide stem-binding segment and a 26 Å-long extended binding site for the sugar backbone ([Fig. 4g](#f4){ref-type="fig"}). The distinct quaternary structures determine the unique activities of AmpDh2 and AmpDh3, notwithstanding the fact that they both hydrolyze the stem peptide from the peptidoglycan. In this sense, the positioning of the dimeric AmpDh2 on the inner leaflet of the outer membrane regulates its activity. AmpDh2 operates on the peripheries of the peptidoglycan, whereby its products are largely found in the soluble fraction. Its specific activity is lower, and it would appear to exhibit selectivity in its reaction, as it shows the presence of a significant partially turned over peptidoglycan. The contrary is true for AmpDh3. This enzyme is soluble, has higher specific activity, and does not leave behind partially hydrolyzed peptidoglycan.

The oligomeric arrangement of AmpDh3 displays two active sites on one side of the tetramer that could perform catalysis on two peptidoglycan strands simultaneously. A mechanism of action has been proposed in which on completion of the reaction with the two bound peptidoglycans, the tetramer would release the product strands and by rotating 60° the two active sites on the opposite side of the tetramer will be aligned to engage two neighboring strands for additional catalysis in a processive manner.^[@B12]^

Conclusion {#s008}
==========

The AmpD enzymes of *P. aeruginosa* are key peptidoglycan amidases linking cell wall recycling processes and antibiotic resistance by repressing β-lactamase induction in Gram-negative bacteria. As discussed in this report, *P. aeruginosa* has evolved three paralogous genes for the AmpD proteases, designated as *ampD*, *ampDh2*, and *ampDh3*. Although these three enzymes share similar catalytic machineries and fold, their activities seem to be differentiated, whereas the cytosolic AmpD is the actual recycling enzyme, the periplasmic AmpDh2 and AmpDh3 are the enzymes involved in turn over of the bacterial cell wall itself and in its maturation. The additional AmpDh2 and AmpDh3 are primarily responsible for removing the peptides from both the exposed and the more sheltered peptidoglycan chains, respectively. From murine models of infection, while the inactivation of *ampD* was not sufficient to affect fitness or virulence of *P. aeruginosa*, double or triple mutants (loss of activities of AmpDh2 and AmpDh3) revealed to be defective in both.^[@B10]^

The oligomerization states and differences in their three-dimensional structures are also related with their localization (membrane, periplasm, cytosol), which in turn influences binding and degradation of the intact cell wall chains or processed (by the actions of lytic transglycosylases and glucosaminidases) peptidoglycan units. The clear differences in specificity, structure, and oligomerization state found among the different AmpD paralogues point to specific functions in bacterial fitness that very likely will be also found in AmpD orthologues distributed in other bacteria. Whereas, as detailed above, clear functions have been assigned for these PG amidases, one cannot rule out additional functions that await discovery. For instance, as muropeptides are generated within the periplasm they are modified by AmpDh2 and AmpDh3. The resultant molecules could potentially be involved in signaling and regulatory events that govern bacterial physiology. This layer of complexity is underscored by the recent elucidation of the structures for at least 20 muropeptides in *P. aeruginosa.*^[@B7]^
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